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Phosphoinositide 3-kinases (PI3K) are key molecular players in male fertility. However, the specific roles of different p110
PI3K catalytic subunits within the spermatogenic lineage have not been characterized so far. Herein, we report that male
mice expressing a catalytically inactive p110 develop testicular hypotrophy and impaired spermatogenesis, leading to a
phenotype of oligo-azoospermia and defective fertility. The examination of testes from p110-defective tubules demon-
strates a widespread loss in spermatogenic cells, due to defective proliferation and survival of pre- and postmeiotic cells.
In particular, p110 is crucially needed in c-Kit–mediated spermatogonial expansion, as c-Kit–positive cells are lost in the
adult testis and activation of Akt by SCF is blocked by a p110 inhibitor. These data establish that activation of the p110
PI3K isoform by c-Kit is required during spermatogenesis, thus opening the way to new treatments for c-Kit positive
testicular cancers.
INTRODUCTION
Phosphoinositide 3-kinases (PI3Ks) are a conserved family
of enzymes (Engelman et al., 2006; Hirsch et al., 2008). Al-
though all PI3Ks share the capacity to phosphorylate the D3
hydroxyl group of phosphatidylinositols (PtdIns), their sub-
strate specificity and molecular structure allow to distin-
guish different classes of PI3Ks. Class IA PI3Ks (PI3K, ,
and ) are heterodimers composed of a catalytic subunit
(p110, , or ) and an adaptor protein comprising a Src
homology 2 domain (p85, p50, p55, p85, or p55). This
class of enzymes is engaged by receptor or Ras activation to
produce the lipid second messenger PtdIns-3,4,5-triphosphate
and to evoke a complex series of signal transduction pathways,
including that of the protein kinase B/Akt (Wymann and
Marone, 2005).
Although the catalytic activity of class I PI3Ks has been
widely involved in several biological processes, including
cell viability and metabolism, the specific contribution of
individual PI3Ks is only beginning to emerge. In particular,
limited data are currently available with respect to p110 in
physiology and disease. Although the genetic deletion of
p110 is embryonic lethal (Bi et al., 2002), we have recently
reported the successful generation of a viable genetically
engineered mouse model expressing a catalytically inactive
form of p110 (Pik3cbK805R mutant; Ciraolo et al., 2008). We
and others have further demonstrated that p110 is specif-
ically required in cell signaling downstream of G protein–
coupled receptors (GPCRs) and tyrosine kinase receptors
(RTKs; Ciraolo et al., 2008; Guillermet-Guibert et al., 2008; Jia
et al., 2008). With respect to RTK pathways, p110 has been
shown to sustain long-term insulin signaling. Accordingly,
the loss of the catalytic activity of p110 results in a pheno-
type of growth retardation and insulin resistance in vivo.
Furthermore, the kinase activity of p110 is specifically re-
quired for PTEN-loss or ERBB2-driven carcinogenesis, sug-
gesting that the pharmacological targeting of p110 may be
a promising therapeutic approach for cancer treatment
(Ciraolo et al., 2008; Jia et al., 2008; Wee et al., 2008).
In the testis, the PI3K-Akt signaling pathway is activated
at different steps of the spermatogenetic process by key
mediators such as the stem cell factor (SCF) and the glial cell
line-derived neurotrophic factor (GDNF; Serve et al., 1994;
Lee et al., 2007). GDNF is secreted by Sertoli cells and has
been shown to stimulate the self-renewal of spermatogonial
stem cells (Kanatsu-Shinohara et al., 2003), whereas SCF
exists in a soluble form and as a membrane-bound growth
factor expressed by Sertoli cells within seminiferous tubules.
The biological effects of SCF are mediated by its RTK recep-
tor c-Kit. In the postnatal testis, c-Kit essentially marks Ley-
dig cells, differentiated spermatogonia, and to a lesser ex-
tent, spermatides and spermatozoa (Besmer et al., 1993;
Rothschild et al., 2003). Through binding to c-Kit, SCF stim-
ulates the proliferation and meiotic progression of sper-
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matogonia (Besmer et al., 1993; Lyman and Jacobsen, 1998;
Sette et al., 2000). Although without indicating the precise
p110 isoform involved, two studies have provided conclu-
sive evidence that PI3Ks are required for the c-Kit/SCF
signaling pathway in the spermatogenic process (Blume-
Jensen et al., 2000; Kissel et al., 2000). In both reports, the
genetic disruption of the c-Kit receptor domain mediating
the molecular interaction with PI3K was associated with
male sterility due to defective proliferation and meiosis, as
well as with increased apoptosis of spermatogonia. More-
over, c-Kit–induced PI3K signaling has also been detected in
Leydig cells, where it controls baseline and stimulated tes-
tosterone secretion (Rothschild et al., 2003).
All these data support the involvement of PI3K in differ-
ent steps of spermatogenesis, such as spermatogonial stem
cell (SSC) as well as spermatogonial proliferation and sur-
vival. However, the specific p110 isoform involved is still
unknown. To develop a greater understanding of the PI3K
isoform implicated in these processes, we studied, using
knock-in mice, the effects of p110 inactivation on testicular
development. We found that in the absence of p110 func-
tion spermatogenesis is dramatically disturbed because of a
progressive reduction in differentiating SSCs as well as a loss
of c-Kit–positive cells. Further in vitro analysis by pharma-
cological inhibition of p110 confirmed this enzyme as the
main PI3K isoform activated downstream of c-Kit. Overall,
this demonstrates a crucial and nonredundant role of p110
in spermatogenesis.
MATERIALS AND METHODS
Mice
The targeting strategy used to generate the PIK3CB805R allele was previously
described (Ciraolo et al., 2008). Results were obtained by using wild-type and
mutant littermates derived from heterozygous crosses of 129/Sv-C57Bl6 ge-
netic background.
Reagents
Antibodies against p110 (sc-602, Western blotting), Erk (sc-93), c-Kit-recep-
tor (sc-168), and GATA-4 (sc-9053; LaVoie, 2003) were from Santa Cruz
Biotechnology (Santa Cruz, CA). The anti-p110 antibody used for immuno-
staining was developed by this laboratory. Antibodies against p85 (4257),
p-akt (Ser473 9271), Akt (9272), and p-Erk (p42–44 MAPK 4695) were from
Cell Signaling Technology (Beverly, MA). The anti-TRA98 antibody was
kindly provided by Dr. Tanaka (Department of Science for Laboratory Animal
Experimentation, Osaka University, Osaka, Japan; Tanaka et al., 1997). The
anti-PLZF antibody was as described (Kovalovsky et al., 2008). Serum testos-
terone and follicle-stimulating hormone (FSH) were measured using immu-
noradiometric assays from IBL International GmbH (Hamburg, Germany).
Protein Analysis
Testes were removed, frozen in liquid nitrogen, and homogenized in lysis
buffer (50 mM Tris-HCl, pH 8, and 150 mM NaCl) supplemented with 2
mg/ml aprotinin, 1 mM pepstatin, 1 ng/ml leupeptin, 50 mM NaF, 2 mM
sodium orthovanadate, 1 mM sodium pyrophosphate, and 1% Triton X-100.
The same buffer was used to solubilize protein extracts from cultured cells.
Homogenates were clarified by centrifugation in a microcentrifuge at 4°C.
Supernatants were analyzed by SDS-PAGE and transferred onto polyvinyli-
dene difluoride membranes. Blots were probed with the indicated anti-
bodies and developed by enhanced chemiluminescence (ECL; Millipore,
Bedford, MA).
Histological Analysis, Apoptosis, and Proliferation
Assays
For histological analysis, testes were fixed in 4% paraformaldehyde (PFA) or
Carnoy (3:1 methanol and acetic acid), embedded in paraffin, and cut into
5-m-thick sections. Sections were stained with hematoxylin and eosin fol-
lowing standard protocols and with specific antibodies.
For the apoptotic assay, 4% paraformaldehyde–fixed and embedded testes
were subjected to TUNEL assay (Roche Applied Science, Indianapolis, IN;
11684817910). For quantization, TUNEL-positive cells were counted for each
tubule in different sections.
For the proliferation assay, sections of fixed testes were stained with an
antibody specific for the proliferation cell nuclear antigen (PCNA; Santa Cruz
Biotechnology; sc-7907) and cyclin D1 (rabbit monoclonal, Novus Biologicals,
Baltimore, MD). Positively stained nuclei were then counted in each tubule by
microscopic examination.
Cell Proliferation and Apoptosis
SSCs were obtained from C57Bl6 mice as previously described by Guan et al.
(2006). SSCs were cultivated in MEM supplemented with 9% FBS and 10
ng/ml GDNF. SSCs were treated with a PI3K (PIK75, 25 nM) and a p110
specific inhibitor (TGX221, 200 nM) or vehicle (DMSO) for 72 h. After 72 h
cells were trypsinized and counted. For the proliferation assay, SSCs were
fixed with 4% paraformaldehyde and stained with the proliferation marker
Ki67 (Novocastra, Newcastle upon Tyne, United Kingdom), numbers were
counted, and the percentage of proliferating cells was calculated in compar-
ison to not-stained cells. Similarly, the analysis of apoptosis of SSC was
performed after treatment with TGX221, PIK75, or DMSO for 72 h. After
fixation cells were subjected to TUNEL assay, and apoptotic cells were
counted in different microscopic fields. The percentage of apoptotic cells was
calculated in comparison to not stained cells.
Phosphoprotein Analysis
SSCs were starved with -MEM containing 9% of FBS for 24 h, treated with
TGX221 and PIK75 or DMSO for 2 h, and stimulated for 5 min with 10 ng/ml
GDNF.
Spermatogones were obtained as following: testes of prepuberal mice were
removed, decapsulated, and digested with a mixture of enzyme that included
collagenase, trypsin, and hyaluronidase. Isolated cells were suspended in
DMEM with addition of 20% FBS and then incubated in a cell culture plate for
2 h. Spermatogones were then collected from the supernatant and starved in
F12 medium for 4 h. Subsequently, cells were stimulated with 100 ng/ml SCF
in the presence p110 inhibitor TGX221 or vehicle.
Statistical Analysis
Statistical significance was calculated with Student’s t test and one-way
analysis of variance tests followed by Bonferroni post hoc analysis. Values are
reported as the mean  SEM.
RESULTS
Loss of p110 Activity Impairs Male Fertility and
Fecundity
Homozygous mice expressing a catalytically inactive p110
(Pik3cbK805R/K805R) were born and reached adulthood (Ciraolo
et al., 2008). Pik3cbK805R/K805R males exhibited a normal
libido and were able to mate with receptive females. How-
ever, the number of litters obtained from mutant males was
significantly reduced (Figure 1A), indicating a defect in male
fertility. On the contrary, homozygous mutant females were
fully fertile. To assess the fecundity of Pik3cbK805R/K805R
males, sperm counts were next performed after isolation
and flushing of the deferens ducts. Indeed, the sperm of
Pik3cbK805R/K805R mice contained significantly fewer sper-
matozoa than wild-type controls (Figure 1B), ranging from
oligozoospermia to azoospermia (67% of Pik3cbK805R/K805R).
At 24 wk of age, when wild-type and mutant mice show
equal body weights (Ciraolo et al., 2008), the testes of
Pik3cbK805R/K805R males were severely reduced in size and
mass compared with those of Pik3cbWT/WT animals (Figure
1C). Immunostaining of Pik3cbK805R/K805R testes confirmed
the widespread expression of p110 in the cells of the sem-
iniferous tubules and interstitium (Figure 1D). It was previ-
ously reported that Pik3cbK805R/K805R mutants show reduc-
tion of the kinase-dead p110 protein levels compared with
WT p110 (Ciraolo et al., 2008). Through Western blotting
(Supplemental Figure 1), we confirmed that the average
expression of p110 also was reduced by 50% in the testes of
Pik3cbK805R/K805R, whereas as previously reported (Ciraolo
et al., 2008), the abundance of other class I PI3Ks was un-
changed (data not shown).
The histological architecture of Pik3cbK805R/K805R and
Pik3cbWT/WT testes was next analyzed. As suggested by the
gross gonadic hypotrophy of Pik3cbK805R/K805R testes, the
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histological organization was severely impaired in the ab-
sence of p110 catalytic activity (Figure 2A). Most strikingly,
the seminiferous tubules of Pik3cbK805R/K805R mice appeared
severely hypocellular compared with those of Pik3cbWT/WT
testes. In addition, focal hyperplasia of the interstitial com-
ponents was observed in mutant testes. Taken together, the
paucity of cells within seminiferous tubules and the oligo-
azoospermia of Pik3cbK805R/K805R males indicate that the loss
of p110 kinase activity is associated with a major spermat-
ogenic defect.
Pik3cbK805R/K805R and Pik3cbWT/WT presented comparable
levels of plasma testosterone (Figure 2B), ruling out a state of
endocrine hypogonadism in mutant mice. Thus, the catalytic
activity of p110 does not appear to be strictly required for
male steroidogenesis. Instead, FSH was significantly higher
in Pik3cbK805R/K805R males (Figure 2C), confirming a condi-
tion of primary gonadic failure in mutant mice. These find-
ings imply that the testicular phenotype of Pik3cbK805R/K805R
males cannot be attributed to an endocrine defect.
Loss of p110 Activity Impairs Spermatogenesis
The histological architecture of Pik3cbK805R/K805R mutants
prompted to a specific loss in one or more cell types within
the seminiferous compartment. To rule out a primitive de-
fect in the migration and development of germ cells in the
testes, postnatal day 5 (P5) testes (i.e., earlier to the begin-
ning of meiotic divisions) were stained for TRA98 (which
marks all types of spermatogonia; Tanaka et al., 1997; Figure
3). At P5, the histological organization of the seminiferous
tubules of Pik3cbK805R/K805R mice was normal and the num-
ber of TRA98-positive cells was similar in mutant and wild-
type tubules, indicating normal PGC migration into gonads
during embryogenesis.
Immunostaining for PLZF (a selective SSC marker) was
then used to examine the stem cell compartment at later
stages. At P10, the number of PLZF-positive cells was com-
parable in Pik3cbK805R/K805R and Pik3cbWT/WT mice, indicat-
ing that the absence of p110 kinase activity allows normal
development of germ cells including SSCs. Instead, in adult
Pik3cbK805R/K805R testes, whereas the number of PLZF-posi-
Figure 1. The absence of p110 activity causes severe testicular
hypotrophy, defective fertility, and fecundity. (A) Number of litters
from mutant mice. Mutant and control mice (n  6) were mated
with receptive female for 6 mo, and the number of litters produced
was counted. (B) Number of spermatozoa obtained from the flush-
ing of the deferens ducts of wild-type (WT) and Pik3cbK805R/K805R
(KR) mice (n 5). Spermatozoa were counted as the number of cells
per microscopic field. Data (number of cells/microscopic field) are
reported as average  SEM; *p  0.05, KR versus WT. (C) Average
weight of testes from Pik3cbWT/WT (WT) and Pik3cbK805R/K805R (KR)
mice (n  10). A representative image of testes dissected from a WT
and a KR mouse is presented. The data (mg/testis) is reported as
average  SEM; ***p  0.001, KR versus WT. (D) Representative
fluorescent immunostaining of testicular sections obtained from
Pik3cbWT/WT and Pik3cbK805R/K805R mice. p110 was detected with a
specific mAb (green), whereas nuclei were stained in red with
DAPI. Scale bar, 50 m.
Figure 2. Histological architecture and endocrine profile of
Pik3cbK805R/K805R mice. (A) Histological architecture of Pik3cbWT/WT
(WT) and Pik3cbK805R/K805R (KR) mice (hematoxylin-eosin staining).
Scale bar, 50 m. (B) Plasma testosterone levels (ng/ml) of adult WT
and KR mice (n  9 WT, 5 KR), measured by ELISA. The difference
is not statistically significant. (C) Plasma FSH levels (ng/ml) of
adult WT and KR mice (WT, n  9; KR, n  5), measured by IRMA.
*p  0.05, KR versus WT.
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tive cells was unchanged, the number of TRA98-positive
cells was significantly reduced. Thus, adult mice lacking
p110 kinase activity presented a significant loss of spermat-
ogenic cells, without detectable changes in the SSC sub-
population. These findings rule out a primary role for p110
in the maintenance of the SSC population in vivo, whereas
p110 kinase activity appears necessary for the normal de-
velopment of SSC-derived cells, including spermatogonia.
Finally, to uncover any concomitant defect in Sertoli and
Leydig cells, testicular sections were stained for GATA-4, a
transcription factor expressed in the testis which marks Ser-
toli and Leydig cells, but not the spermatogenic lineage
(LaVoie, 2003). As shown in Figure 3, Pik3cbK805R/K805R mice
presented a normal number of Sertoli cells in the seminifer-
ous tubules, and no apparent defect was evident in their
position, cell volume, and morphology. In addition, the
GATA-4 staining of the interstitium of Pik3cbK805R/K805R
testes did not reveal a loss of Leydig cells (Figure 3). Thus, the
disruption of the seminiferous tubules in Pik3cbK805R/K805R
mice is attributable to an intrinsic defect of the spermatogenic
lineage and does not involve Sertoli and Leydig cells.
p110 Is Not Required for SSC Proliferation
SSC proliferation is known to critically depend on the acti-
vation by GDNF of the PI3K pathway leading to Akt phos-
phorylation (Lee et al., 2007). To gain insight into the specific
function of different PI3K isoforms in this process, primary
cultures of SSCs were established as previously described
and cultured in the presence of GDNF (Guan et al., 2009).
Because p110 is a known key player in the proliferative
response to growth factors, we tested the effects of a selec-
tive p110 inhibitor (TGX221) as well as of a less selective
PI3K inhibitor mainly blocking p110 (PIK75) on the GDNF-
driven cell growth of SSC. After 3 d of culture, the growth
response to GDNF was slightly reduced by treatment with
TGX221 but completely blunted by PIK75 (Figure 4A). In
agreement, PIK75 but not TGX221 administration reduced
expression of the proliferation marker Ki67 (Figure 4B and
Supplemental Figure 2). Furthermore, PIK75-treated SSC
showed reduced levels of cyclin D1 compared with vehicle-
treated cells, whereas cyclin D1 expression was unaffected by
TGX221 (Figure 4C). Taken together, these findings indicate
that p110 and not p110 is required for GDNF-induced SSC
proliferation in culture. Accordingly, PIK75 and not TGX221
blunted GDNF-induced Akt phosphorylation, suggesting that
p110 is the main PI3K isoform activated by GDNF (Figure 4D).
Finally, because the PI3K pathway controls both cell pro-
liferation and death, the apoptosis of SSC was next assessed
in the presence of both inhibitors. As shown in Figure 4E
and Supplemental Figure 2, incubation with either TGX221
or PIK75 slightly but significantly increased the apoptotic
rate of cultured SSC.
p110 Activity Is Required for the Proliferation and
Survival of Spermatogones
Our findings suggested that the role of p110 in the sper-
matogenic process involves SSC-derived cells and not the
stem cell compartment. To assess whether p110 is required
for the growth and maintenance of spermatogones, we then
analyzed markers of proliferation and survival at P10, a time
characterized by high grade proliferation and differentiation
of type A spermatogones. In P10 Pik3cbK805R/K805R pups,
actively proliferating PCNA-positive cells within the semi-
niferous tubules were indeed reduced by nearly 50% com-
pared with controls (Figure 5A). Moreover, the proportion
of cyclin D1–positive cells was strikingly reduced in mutant
tubules compared with the widespread expression of cyclin
D1 in wild-type controls. A similar finding was also ob-
served in adult testes, thus confirming that p110 is strictly
required in vivo for the proliferation of spermatogones.
Furthermore, TUNEL staining of P10 testes uncovered a
2.5-fold increase in apoptosis within the seminiferous tu-
bules of Pik3cbK805R/K805R mice, whereas only a few cells
were TUNEL-positive in Pik3cbWT/WT testes (Figure 5B).
These findings suggested that the loss p110 kinase activity
results in a dual disruption of spermatogonial proliferation
and survival in the mouse testis.
SCF Requires p110 to Activate Akt Downstream of the
c-Kit Receptor
Similar to p110 inactivation, the genetic disruption of PI3K
signaling downstream of the c-Kit receptor (c-KitY719F mu-
tant) causes an early spermatogonial differentiation block,
Figure 3. Loss of spermatogones in adult Pik3cbK805R/K805R testes.
Representative immunostaining for Tra98 (marking undifferenti-
ated spermatogones), PLZF (marking SSCs), and Gata-4 (L, Leydig
cells; S, Sertoli cells) of testicular sections obtained from postnatal
days 5 and 10 (P5 and P10) and week 16 (W16) Pik3cbWT/WT (left)
and Pik3cbK805R/K805R mice (right). Testes were fixed in Carnoy and
PFA, and immunostaining was obtained with a secondary antibody
linked to HRP (appearing in brown and red), whereas counterstain-
ing was performed with hematoxylin. Black arrows, SSCs. Scale bar,
50 m.
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associated with reduced proliferation and extensive apopto-
sis of spermatogones (Blume-Jensen et al., 2000; Kissel et al.,
2000). To test the involvement of p110 in c-Kit dependent
spermatogenesis, we first analyzed the expression of c-Kit in
Pik3cbK805R/K805R adult testes. As shown in Figure 6A, im-
munostaining for the c-Kit receptor revealed that mutant
seminiferous tubules lost c-Kit–positive cells, whereas exten-
sive c-Kit immunoreactivity was evident within the seminif-
erous tubules of Pik3cbWT/WT testes. Nonetheless, mutant
testes regularly showed c-Kit–positive interstitial Leydig
cells. Because the c-Kit receptor also marks type A and type
B spermatogones, and to a lesser extent spermatides and
spermatozoa, these findings confirmed that the blockade of
p110 function selectively affects the spermatogenic lineage
and leads to the loss of c-Kit–positive cells.
The present finding suggested a key role for the p110
signaling downstream of the c-Kit receptor in spermato-
gones. To directly test this hypothesis and to better define
the involvement of p110 in the SCF/c-Kit signaling path-
way, we next isolated nonadherent primary spermatogonial
cells from prepubertal Pik3cbWT/WT males. As previously
reported (Besmer et al., 1993), these cells expressed the c-Kit
receptor (not shown). Cells were thus treated with SCF (100
ng/ml, 5 min) in the presence of a selective p110 inhibitor
(TGX221, 200 nM) or vehicle (DMSO), and triggering of Akt
phosphorylation was next assayed. As shown in Figure 6, B
and C, treatment of primary spermatogonia with SCF in-
duced a rapid phosphorylation of Akt, which indicated sig-
naling through PI3K downstream of the c-Kit receptor. Of
note, the SCF-dependent Akt phosphorylation was blunted
by cotreatment of primary spermatogonia with TGX221. Taken
together, these findings provide in vitro evidence that p110 is
critically required for c-Kit signaling in spermatogones.
DISCUSSION
The present findings establish p110 as a crucial PI3K iso-
form controlling spermatogenesis. In mice expressing a ki-
nase-dead p110 (Pik3cbK805R/K805R), testicles were hypotro-
phic and spermatogenesis was severely impaired, whereas
somatic cells (Sertoli and Leydig) and plasma testosterone
levels were unaffected. Therefore, the oligo-azoospermia of
Pik3cbK805R/K805R mice was associated with the absence of
p110 activity specifically within the spermatogenic lineage.
In agreement, the increased FSH levels in mutant mice
might indicate feedback pituitary activation in response to
primary gonadic failure. Furthermore, this is in line with
previous reports, where increased levels of gonadotropins
have been observed in mice devoid of PI3K signaling down-
stream of the c-Kit receptor (Rothschild et al., 2003).
Despite a major loss within the spermatogenic lineage,
Pik3cbK805R/K805R mice did not exhibit a detectable decrease
in PLZF-positive spermatogenic cells, which represent the
SSC population. In line with this observation, the selective
pharmacological inhibition of p110 on cultured SSC did not
significantly affect their capacity to proliferate, although a
minor increase in their apoptotic rate was observed. How-
ever, this subtle change appears to be fully compensated in
vivo. The negligible role of p110 in SSC survival and pro-
liferation could be supported by the marginal contribution
of p110 to Akt phosphorylation upon GDNF stimulation,
as shown by the minor effect of TGX221 in this context.
During embryonic development, SSC originate from a pool
of embryonic precursors, the primordial germ cells (PGCs;
De Felici, 2000; Saga, 2008). At 10 d postcoitum (dpc), PGCs
begin to move by active migration from the endoderm into
the gonadal ridges, where they start to differentiate (12.5
dpc) in SSCs. During this stage, the SCF is the major growth
factor sustaining PGC migration, survival, and proliferation
through its binding and activation of the c-Kit receptor
(Saga, 2008). Although we demonstrate that c-Kit is poten-
tially able to signal through p110 in spermatogenic cells,
we did not observe alterations in the migration and num-
ber of PGCs. This is in line with previous reports, which
have shown that the c-Kit receptor does not require PI3K
Figure 4. The absence of p110 activity re-
duces the survival but does not affect the pro-
liferation of SSCs. (A) Inhibition of cell prolif-
eration of SSCs by a specific p110 or p110
inhibitor: TGX221 (200 nM) or PIK75 (25 nM),
respectively. Cells were treated with TGX221
or PIK75 for 72 h in the presence or absence of
GDNF, and the relative growth was calculated
in comparison to day 0. (B) Proliferation anal-
ysis. SSCs were treated with TGX221 and
PIK75 for 72 h in the presence of GDNF, fixed
with 5% PFA, and stained for Ki67, a positive
marker for cell proliferation. The percentage of
Ki67-positive cells was measured in more than
10 microscope fields. (C) Analysis of cell cycle
markers. Cells were treated with TGX221 or
PIK75 for 72 h in the presence or absence of
GDNF, and the expression of cyclin D1 was
analyzed by Western blot. (D) Analysis of Akt
phosphorylation in response to GDNF after
treatment with TGX221 or PIK75. SSCs were
treated for 1 h with inhibitors and stimulated
with 10 ng/ml GDNF. Left, a representative
Western blot is presented. Right, bars repre-
sent the quantification of phosphorylated Akt
on Ser473 (n  6; **p  0.001). (E) Analysis of
apoptosis after treatment with TGX221 or
PIK75. After 72 h of treatment, the percentage
of apoptotic cells was quantified by TUNEL
assay.
E. Ciraolo et al.
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signaling during the earlier stages of gonadic development
(Blume-Jensen et al., 2000; Kissel et al., 2000). Taken together,
our results thus support the view that p110 is neither
necessary for the migration and proliferation of PGCs in the
Figure 6. p110 activates Akt downstream of the c-Kit receptor in spermatogones (A) Analysis of c-Kit–positive cells in Pik3cbWT/WT and
Pik3cbK805R/K805R adult testis. Testes were fixed with 4% PFA (top) or Carnoy (bottom), and sections were stained with an antibody specific
for the c-Kit receptor (marking Leydig cells and spermatogones). Scale bar, 50 m. (B) Analysis of Akt and Erk phosphorylation after
treatment with TGX221. Isolated spermatogones were treated with 200 nM TGX221 and stimulated with 100 ng/ml SCF. A representative
Western blot is presented. (C) Bars represent the quantification of Akt phosphorylation on Ser473 (n  6; **p  0.01).
Figure 5. The absence of p110 activity re-
duces the survival of the spermatogenic lineage.
(A) Number of actively proliferating PCNA and
cyclin D1–positive cells in testicular sections of
Pik3cbWT/WT (WT) and Pik3cbK805R/K805R (KR)
testes obtained from postnatal day 10 (P10) and
adult (W8) mice. Representative immunostain-
ing for PCNA and cyclin D1 of a WT and a KR
section are presented. PCNA and cyclin D1–pos-
itive cells appear in brown and red, respectively,
whereas counterstaining was performed with
hematoxylin. PCNA-positive cells were counted
for each tubule in different sections. Data are
presented as average  SEM (n  5 animals per
genotype); ***p 0.001 KR versus WT. (B) Num-
ber of TUNEL-positive cells in tubules from WT
and KR mice. Representative micrographs are
shown. TUNEL staining appears as a red fluo-
rescence, whereas nuclei were stained with
DAPI (blue). The data (number of TUNEL-posi-
tive cells/microscopic field) are reported as
average  SEM (n  5 animals per genotype);
*p  0.05 KR versus WT. Scale bar, 50 m.
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embryonic gonads, nor for the maintenance of the SSC pop-
ulation in the adult testis, whereas this enzyme is critically
involved in later developmental stages. This finding is rele-
vant, because p110 has been implied in the regulation of
the self-renewal and pluripotency of embryonic stem cells
(Kingham and Welham, 2009). Thus, the participation of
p110 in the biology of stem cells may be strictly dependent
upon their specific machinery. Instead, we report that the
pharmacological inhibition with the potent PI3K inhibitor
PIK75 could limit SSC proliferation in vitro, by blunting
GDNF-induced Akt activation. Although in vivo studies are
necessary to fully address this issue, it is reasonable that
p110 was the isoform blocked by PIK75 and involved in
controlling the self-renewal of SSC. Accordingly, treatment
with other pan-PI3K inhibitors is already known to prevent
SSC self-renewal (Lee et al., 2007).
The absence of p110 activity caused a dramatic loss of
spermatogones and their more differentiated progeny, thus
implying the involvement of p110 in the signaling of a
crucial agonist of spermatogonial expansion and differenti-
ation such as SCF. This growth factor is known to trigger the
class IA PI3K/Akt axis to promote spermatogenesis, as ge-
netic deletion of the PI3K-binding site on c-Kit (c-KitY719F)
causes azoospermia (Blume-Jensen et al., 2000; Kissel et al.,
2000). Interestingly, our results indicate that the lack of
p110 activity closely phenocopied this c-Kit mutation.
Indeed, because SCF-dependent Akt activation was sig-
nificantly blocked in spermatogones after treatment with
TGX221, it is reasonable that Akt phosphorylation down-
stream of c-Kit mostly depended on p110. Consistent with
the role of p110 downstream c-Kit, adult Pik3cbK805R/K805R
testes lost both c-Kit–positive type B spermatogones and
spermatocytes. However, the presence of a residual sperma-
tozoa production, albeit not adequate to support full fertil-
ity, might not completely rule out a minor role for p110 in
spermatogenesis.
Recent studies have reported that p110 activity is mainly
associated with GPCRs (Guillermet-Guibert et al., 2008).
However, the engagement of PI3K by RTKs has also
emerged in multiple cell types (Ciraolo et al., 2008; Guiller-
met-Guibert et al., 2008; Jia et al., 2008; Canobbio et al., 2009).
In mast cells, c-Kit selectively couples to PI3K, modulating
the proliferation, adhesion, and migration of these cells (Ali
et al., 2004). However, p110 expression is restricted to leu-
kocytes and is absent in the spermatogenic lineage. Overall,
these observations support the view that c-Kit drives differ-
ent PI3K isoenzymes in distinct cell types and that in gen-
eral, selected RTKs may preferentially signal through p110
or p110 and not through p110, depending on the cellular
contexts. Because fully selective p110 inhibitors are not yet
commercially available, further studies are needed to under-
stand whether this isoform cooperates with p110 in c-Kit–
mediated spermatogenesis. However, independently of
p110, p110 may be engaged by RTKs through a possible
cross-talk between c-Kit and a GPCR yet to be determined.
Similarly, it cannot be excluded that p110 activation by
c-Kit receptor may be mediated by Ras activation (Marques
et al., 2009).
The present findings may have critical implications for the
development and therapeutic use of the PI3K inhibitors
currently under development and/or assessment in clinical
trials. Our data, indeed, imply potential side effects on male
fertility of drugs targeting the p110 isoform but also open
the way to the use of more selective PI3K inhibitors in
c-Kit–positive testicular cancers.
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